Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Macrophage activation syndrome (MAS) is part of a spectrum of cytokine storms. This case report describes a presentation of an 18-year-old female with systemic lupus erythematosus (SLE) complicated by MAS. The patient, previously healthy, presented with a 3-week history of high-grade intermittent fever, abdominal pain, nausea, and loss of appetite. Clinical examination revealed fever, tachycardia, and normal blood pressure without signs of lymphadenopathy or organomegaly. Laboratory tests indicated anemia, thrombocytopenia, leukopenia, neutropenia, elevated liver enzymes, hyperferritinemia, hypofibrinogenemia, and hypertriglyceridemia. Despite broad-spectrum antimicrobial therapy, the patient's fever persisted, prompting bone marrow aspiration, which showed hemophagocytosis. Immunological testing revealed elevated antinuclear antibodies, anti-double-stranded DNA, and anti-Smith antibodies, confirming a diagnosis of SLE. Further analysis using the Modified Histocyte score and hemophagocytic lymphohistiocytosis-2004 criteria supported a diagnosis of MAS associated with SLE. The patient was treated with intravenous methylprednisolone, followed by oral prednisolone and monthly cyclophosphamide. The patient showed significant clinical improvement with the resolution of fever and hematological abnormalities. MAS is a rare but severe complication of SLE, requiring early recognition and treatment to prevent life-threatening complications like multiorgan failure. This case highlights the importance of considering MAS in young females with SLE presenting with systemic symptoms and emphasizes using diagnostic scoring systems to guide management. Early intervention and careful monitoring are crucial to improving patient outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.4103/aam.aam_99_25DOI Listing

Publication Analysis

Top Keywords

macrophage activation
8
activation syndrome
8
systemic lupus
8
lupus erythematosus
8
mas
5
sle
5
cytokine storm
4
storm unveiled
4
unveiled diagnostic
4
diagnostic challenges
4

Similar Publications

The effect of CD40 agonist antibody therapy on the pancreatic cancer microenvironment.

Naunyn Schmiedebergs Arch Pharmacol

September 2025

Department of Gastroenterology, Jinhua Central Hospital, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China.

The fourth leading cause of cancer-related fatalities in the USA is pancreatic ductal adenocarcinoma (PDAC), a particularly deadly illness that is resistant to immunotherapy. One of the Main Obstacles in cancer research is developing better treatments for PDAC, which has the lowest 5-year survival rate of any malignancy. Anti-CTLA-4, anti-PD-L1, and anti-PD-1 immune checkpoint blockade medications also have poor results in these patients, which may indicate the presence of other immunosuppressive mechanisms in the pancreatic tumor microenvironment (TME).

View Article and Find Full Text PDF

Neutrophils in Myocarditis: A Focus on the Secretory and Phagocytotic Functions.

Rev Cardiovasc Med

August 2025

Henan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, 453003 Xinxiang, Henan, China.

Myocarditis is a life-threatening inflammatory disorder that affects the cardiac muscle tissue. Current treatments merely regulate heart function but fail to tackle the root cause of inflammation. In myocarditis, the initial wave of inflammation is characterized by the presence of neutrophils.

View Article and Find Full Text PDF

Polystyrene nanoplastics reprogramed pulmonary metabolisms mediated by immune regulation of myeloid hypoxia-inducible factor 1α.

Environ Int

September 2025

State Key Laboratory of Environmental Chemistry and Toxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China; College of Sciences, Northeastern University, Shenyang 110004, China; School of Environment, Hangzhou Institute for Advanced Study, Univ

Exposure to nanoplastics (NPs), a pervasive environmental pollutant, presents potential health risks. Pulmonary exposure to NPs has been shown to disrupt both pulmonary metabolic status and immune homeostasis, leading to concerns about their impact on respiratory health and systemic well-being. However, the underlying linkage and mechanisms remain elusive.

View Article and Find Full Text PDF

Macrophages (MΦs) are integral cellular components responsible for immune response and tissue homeostasis. Evaluation of their pro-inflammatory (M1) and anti-inflammatory (M2) polarization states, along with their metabolic profiles, typically conducted via flow cytometry, is crucial for assessing the immune status of an organism. Traditional flow cytometry relies on extrinsic fluorescent labels, which may interfere with cellular function.

View Article and Find Full Text PDF

Oridonin mitigates bacterial pneumonia by regulating mitochondrial integrity and ferroptosis via targeting KEAP1/NRF2 signaling.

Biochem Pharmacol

September 2025

Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Institute of Translational Medicine, Zhejiang Shuren University, 310015 Hangzhou, China. Electronic address:

Methicillin-resistant Staphylococcus aureus (MRSA) is a highly virulent and drug-resistant pathogen frequently causing bacterial pneumonia. Currently, there are limited effective treatments available due to the rapidly evolving resistance of bacteria. Therefore, there is an urgent need to develop novel therapies that focus on host-pathogen interactions.

View Article and Find Full Text PDF